Mouse corneal lymphangiogenesis model (original) (raw)

Nature Protocols volume 6, pages 817–826 (2011)Cite this article

Subjects

Abstract

This protocol describes a powerful in vivo method to quantitatively study the formation of new lymphatic vessels in the avascular cornea without interference of pre-existing lymphatics. Implantation of 100 ng of lymphangiogenic factors such as vascular endothelial growth factor (VEGF)-A, VEGF-C or fibroblast growth factor-2, together with slow-release polymers, into a surgically created micropocket in the mouse cornea elicits a robust lymphangiogenic response. Newly formed lymphatic vessels are detected by immunohistochemical staining of the flattened corneal tissue with lymphatic endothelial-specific markers such as lymphatic vessel endothelial hyaluronan receptor-1; less-specific markers such as vascular endothelial growth factor receptor 3 may also be used. Lymphatic vessel growth in relation to hemangiogenesis can be readily detected starting at day 5 or 6 after pellet implantation and persists for ∼14 d. This protocol offers a unique opportunity to study the mechanisms underlying lymphatic vessel formation, remodeling and function.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Cao, Y. Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis. Nat. Rev. Cancer 5, 735–743 (2005).
    Article CAS PubMed Google Scholar
  2. Alitalo, K., Tammela, T. & Petrova, T.V. Lymphangiogenesis in development and human disease. Nature 438, 946–953 (2005).
    Article CAS PubMed Google Scholar
  3. Makinen, T. et al. Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat. Med. 7, 199–205 (2001).
    Article CAS PubMed Google Scholar
  4. Cao, R. et al. Hepatocyte growth factor is a lymphangiogenic factor with an indirect mechanism of action. Blood 107, 3531–3536 (2006).
    Article CAS PubMed Google Scholar
  5. Cao, R. et al. PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis. Cancer Cell 6, 333–345 (2004).
    Article CAS PubMed Google Scholar
  6. Bjorndahl, M. et al. Insulin-like growth factors 1 and 2 induce lymphangiogenesis in vivo. Proc. Natl. Acad. Sci. USA 102, 15593–15598 (2005).
    Article PubMed PubMed Central Google Scholar
  7. Cao, R. et al. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ. Res. 94, 664–670 (2004).
    Article CAS PubMed Google Scholar
  8. Kubo, H. et al. Blockade of vascular endothelial growth factor receptor-3 signaling inhibits fibroblast growth factor-2-induced lymphangiogenesis in mouse cornea. Proc. Natl. Acad. Sci. USA 99, 8868–8873 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  9. Cao, Y. et al. Vascular endothelial growth factor C induces angiogenesis in vivo. Proc. Natl. Acad. Sci. USA 95, 14389–14394 (1998).
    Article CAS PubMed PubMed Central Google Scholar
  10. Joukov, V. et al. Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J. 16, 3898–3911 (1997).
    Article CAS PubMed PubMed Central Google Scholar
  11. Bjorndahl, M.A. et al. Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis. Cancer Res. 65, 9261–9268 (2005).
    Article PubMed Google Scholar
  12. Bruyere, F. et al. Modeling lymphangiogenesis in a three-dimensional culture system. Nat. Methods 5, 431–437 (2008).
    Article CAS PubMed Google Scholar
  13. Kerjaschki, D. et al. Lymphatic endothelial progenitor cells contribute to de novo lymphangiogenesis in human renal transplants. Nat. Med. 12, 230–234 (2006).
    Article CAS PubMed Google Scholar
  14. Ny, A. et al. A genetic Xenopus laevis tadpole model to study lymphangiogenesis. Nat. Med. 11, 998–1004 (2005).
    Article CAS PubMed Google Scholar
  15. Nagy, J.A. et al. Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J. Exp. Med. 196, 1497–1506 (2002).
    Article CAS PubMed PubMed Central Google Scholar
  16. Maruyama, K. et al. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages. J. Clin. Invest. 115, 2363–2372 (2005).
    Article CAS PubMed PubMed Central Google Scholar
  17. Rogers, M.S., Birsner, A.E. & D'Amato, R.J. The mouse cornea micropocket angiogenesis assay. Nat. Protoc. 2, 2545–2550 (2007).
    Article CAS PubMed Google Scholar
  18. Cao, R. et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat. Med. 9, 604–613 (2003).
    Article CAS PubMed Google Scholar
  19. Bock, F. et al. Improved semiautomatic method for morphometry of angiogenesis and lymphangiogenesis in corneal flatmounts. Exp. Eye. Res. 87, 462–470 (2008).
    Article CAS PubMed Google Scholar
  20. Cursiefen, C. et al. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113, 1040–1050 (2004).
    Article CAS PubMed PubMed Central Google Scholar
  21. Albuquerque, R.J. et al. Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth. Nat. Med. 15, 1023–1030 (2009).
    Article CAS PubMed PubMed Central Google Scholar
  22. Nakao, S. et al. Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains. FASEB J. 24, 504–513 (2010).
    Article CAS PubMed PubMed Central Google Scholar
  23. Regenfuss, B. et al. Genetic heterogeneity of lymphangiogenesis in different mouse strains. Am. J. Pathol. 177, 501–510 (2010).
    Article CAS PubMed PubMed Central Google Scholar
  24. Rohan, R.M., Fernandez, A., Udagawa, T., Yuan, J. & D'Amato, R.J. Genetic heterogeneity of angiogenesis in mice. FASEB J. 14, 871–876 (2000).
    Article CAS PubMed Google Scholar

Download references

Acknowledgements

Our laboratory was supported through research grants from the Swedish Research Council, the Swedish Cancer Foundation, the Karolinska Institute Foundation, the Karolinska Institute distinguished professor award, the European Union Integrated Project of Metoxia (Project no. 222741) and the European Research Council Advanced Grant ANGIOFAT (Project no. 250021). Y.C. is supported by the Swedish Heart and Lung Foundation.

Author information

Author notes

  1. yihai.cao@ki.se

Authors and Affiliations

  1. Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    Renhai Cao, Sharon Lim, Hong Ji, Yin Zhang, Yunlong Yang, Jennifer Honek & Eva-Maria Hedlund
  2. Department of Medicine and Health Sciences, Linköping University, Linköping, Sweden
    Yihai Cao

Authors

  1. Renhai Cao
  2. Sharon Lim
  3. Hong Ji
  4. Yin Zhang
  5. Yunlong Yang
  6. Jennifer Honek
  7. Eva-Maria Hedlund
  8. Yihai Cao

Contributions

Y.C. designed the study. R.C. conducted the experiments. R.C., S.L., H.J., Y.Z., Y.Y., J.H., E.-M.H. and Y.C. analyzed the data. R.C., S.L., H.J., Y.Z., Y.Y., J.H. and Y.C. participated in designing and discussing this study. R.C., S.L. and Y.C. wrote the paper.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Cao, R., Lim, S., Ji, H. et al. Mouse corneal lymphangiogenesis model.Nat Protoc 6, 817–826 (2011). https://doi.org/10.1038/nprot.2011.359

Download citation

This article is cited by